Does USTEKINUMAB Cause Post procedural infection? 150 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 150 reports of Post procedural infection have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.2% of all adverse event reports for USTEKINUMAB.
150
Reports of Post procedural infection with USTEKINUMAB
0.2%
of all USTEKINUMAB reports
4
Deaths
89
Hospitalizations
How Dangerous Is Post procedural infection From USTEKINUMAB?
Of the 150 reports, 4 (2.7%) resulted in death, 89 (59.3%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Post procedural infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 150 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Post procedural infection?
ADALIMUMAB (1,109)
ETANERCEPT (362)
METHOTREXATE (226)
INFLIXIMAB (223)
UPADACITINIB (188)
TOFACITINIB (184)
GOLIMUMAB (177)
VEDOLIZUMAB (166)
RISANKIZUMAB-RZAA (157)
ABATACEPT (136)
Which USTEKINUMAB Alternatives Have Lower Post procedural infection Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE